Anúncio
Anúncio

IDXX

IDXX logo

Idexx Laboratories Inc

713.01
USD
Patrocinado
+6.18
+0.87%
07 de jan., 10:00 UTC -5
Abrir

Relatórios de Lucros IDXX

Rácio de surpresa positiva

IDXX separação 37 de 39 últimas estimativas.

95%

Próximo Relatório

Data do Próximo Relatório
02 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.09B
/
$2.98
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-0.98%
/
-12.35%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+14.68%
/
+13.74%

Idexx Laboratories Inc earnings per share and revenue

On 03 de nov. de 2025, IDXX reported earnings of 3.40 USD per share (EPS) for Q3 25, beating the estimate of 3.19 USD, resulting in a 6.47% surprise. Revenue reached 1.11 bilhão, compared to an expected 1.09 bilhão, with a 1.01% difference. The market reacted with a +14.84% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 15 analistas forecast an EPS of 2.98 USD, with revenue projected to reach 1.09 bilhão USD, implying an diminuir of -12.35% EPS, and diminuir of -0.98% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
06 de jan. de 2026 Para Q2 26
Estimativa
-$0.10
Real
$0.00
Surpresa
+100.00%
FAQ
For Q3 2025, Idexx Laboratories Inc reported EPS of $3.40, beating estimates by 6.47%, and revenue of $1.11B, 1.01% above expectations.
The stock price moved up 14.84%, changed from $629.51 before the earnings release to $722.94 the day after.
The next earning report is scheduled for 02 de fev. de 2026.
Based on 15 analistas, Idexx Laboratories Inc is expected to report EPS of $2.98 and revenue of $1.09B for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio